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Dear Editor, We read with interest your article on the use of gabapen-tin pain control after burn debridement (1). Gabapentin has a well-established role in the management of neuro-pathic pain, and has been investigated in the past decade regarding its ability to potentiate the effect of morphine on postoperative pain, or decrease the amount of pain ex-perienced by patients after surgery. This study represents one of the only randomized, placebo-controlled, double-blind studies to look at gabapentin in burn patients. The authors found that 1200mg of gabapentin 2 hours prior to operative debridement of burn wounds led to a signifi-cant decrease in pain in the immediate 24-hour postoper-ative period, as measured by the visual analog score and by patient-requested morphine consumption. While the results are important and consistent with the growing body of literature, there remain methodological ques-tions that are not addressed (2-4).First, while the authors state that total burn surface area in all patients were comparable (average of 13% ± 25 in the placebo group versus 19% ± 29 in the gabapentin group), 
there are several additional characteristics that can sig-nificantly affect pain, both pre-and post-operatively. Burn severity, type of burn (flame, chemical) and location on the body are not addressed here. In addition, the extent of debridement must also be considered, with regard to both surface area and depth.  Conditions such as infec-tion or other complicating medical conditions are also not mentioned in the article, which can be common in burn patients, and which can significantly affect patient outcome. Secondly, neuropathic pain induced by burns can lead to chronic and debilitating pain; this should be evaluated, depending on the feasibility of follow-up. The authors state that “Fassoulaki et al. (5) were unable to demonstrate a decrease in analgesic consumption and VAS scores at rest or after movement during the first 24h after the operation” due to “differences in the types of surgeries performed.” In fact, however, Fassoulaki et al. (5) were able to find that gabapentin reduced require-ment for analgesics and led to decreased pain with move-ment within the first week post-operatively; the caveat was that this difference did not persist long-term (at 10 days or 3 months). Because chronic pain control can be 
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such an important aspect of clinical outcomes in burn 
patients, this is critical to consider when thinking about 
impact on changes in management.
In summary, this study provides important support for 
the use of gabapentin in postoperative pain, and repre-
sents one of the only studies to address its use in burn pa-
tients. However, several questions regarding the clinical 
condition of patients (burn severity, type of burn, loca-
tion of burn, extent of debridement, and presence of in-
fection) must be considered; long-term sequelae with re-
gard to chronic pain must also be addressed. All of these 
variables must be taken into account before the true im-
pact of gabapentin in these patients can be determined.
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